Product Description: Epobis, a dendrimeric peptide, is a recombinant form of erythropoietin. Epobis is a potent erythropoietin receptor agonist. Epobis promotes neuritogenesis in primary motoneurons. Epobis decrease TNF release and crosses the blood-brain barrier. Epobis has anti-inflammatory and memory enhancing properties[1].
Applications: COVID-19-immunoregulation
Formula: C100H151N27O29
References: [1]Dmytriyeva O, et, al. Epobis is a Nonerythropoietic and Neuroprotective Agonist of the Erythropoietin Receptor with Anti-Inflammatory and Memory Enhancing Effects. Mediators Inflamm. 2016;2016:1346390.
CAS Number: 915091-83-7
Molecular Weight: 2195.44
Compound Purity: 99.34
Research Area: Inflammation/Immunology; Neurological Disease
Solubility: DMSO : 4 mg/mL (ultrasonic)/H2O : ≥ 50 mg/mL
Target: TNF Receptor